Synthesis of Mn2O3 Nanoparticles and Determination of Its Inhibition Effect On Sera of Iraqi Patients with Diabetes Mellitus Type-2 and Diabetes Nephropathy

Authors

  • Layth Tawfeeq Ali Medical city, Ministry of Health, Baghdad, Iraq
  • Hanaa H. Hussein Department of Chemistry, College of Science, Al-Mustansiriyah University, Baghdad, Iraq
  • Salma Abdul Rudha Abbas Department of Chemistry, College of Science, Al-Mustansiriyah University, Baghdad, Iraq

DOI:

https://doi.org/10.22401/7gfa1v29

Keywords:

Arginase enzyme, diabetes nephropathy, diabetes type 2, Manganese oxide Nanoparticles

Abstract

Manganese is essential for the synthesis of antioxidant enzymes and metabolic issues in Diabetes type 2 (DMT2), which is a worldwide disease, Chronic metabolic disorders cause insulin resistance, hyperglycemia, and complications like diabetic nephropathy. Arginase converts arginine to ornithine and urea. Increased arginase activity in DMT2 and diabetes nephropathy (DN) which has been linked to kidney damage, and arginase inhibitors can increase NO which is essential to vascular function. However, the molecular mechanisms of arginase disregulation are in DMT2 and DN are still unclear. This study examined the effect of manganese oxide nanoparticles (Mn2O3 NPs) on arginase activity inhibition in serum samples from DMT2 and DN patients. We hypothesized that Mn2O3 NPs alter cell redox status and signaling pathways, affecting DMT2 and DN arginase activity. We used a colorimetric assay to measure arginase activity in 80 serum samples from DMT2 and DN patients treated with different MnO2 NP concentrations to test our hypothesis. The current study characterized nanoparticles using various techniques such as IR, SEM, AFM, XRD, and EDX, which found it within nanoscale nature. Our findings are that Mn2O3 NPs modulate arginase activity specificity in DM2 samples. Suggestions Mn2O3 NPs could be used to develop new treatments for these conditions.

References

Mehri, A.; "Trace elements in human nutrition (II)–an update". Int. J. Prev. Med., 11(1): 2, 2020.

Shaukat, A.; Anwar, H.; Mahmood, A.; Hussain, G.; Rasul, A.; Umar, M.; et al.; "Synthesis cum characterization of MgO and MnO nanoparticles and their assessment as antidiabetic and antioxidative agents in diabetic rat model". Phys. B (Amsterdam, Neth.), 602: 0921-4526, 2021.

Lu, L.; Huang, M.; Huang, Y.; Corvini, P.F.-X.; Ji, R.; Zhao, L.; "Mn3O4 nanozymes boost endogenous antioxidant metabolites in cucumber (Cucumis sativus) plant and enhance resistance to salinity stress". Environ. Sci. Nano, 7(6): 1692-1703, 2020.

Singh, N.; Geethika, M.; Eswarappa, S.M.; Mugesh, G.; "Manganese‐Based Nanozymes: Multienzyme Redox Activity and Effect on the Nitric Oxide Produced by Endothelial Nitric Oxide Synthase". Chem.–Eur. J., 24(33): 8393-8403, 2018.

Chavali, M.S.; Nikolova, M.P.; "Metal oxide nanoparticles and their applications in nanotechnology". SN Appl. Sci., 1(6): 607, 2019.

Cai, X.; Zhu, Q.; Zeng, Y.; Zeng, Q.; Chen, X.; Zhan, Y.; "Manganese oxide nanoparticles as MRI contrast agents in tumor multimodal imaging and therapy". Int. J. Nanomed., 14: 8321–8344, 2019.

Hussain, T.; Tan, B.; Murtaza, G.; Liu, G.; Rahu, N.; Saleem, M et al.; "Flavonoids and type 2 diabetes: Evidence of efficacy in clinical and animal studies and delivery strategies to enhance their therapeutic efficacy". Pharmacol. Res., 152: 104629, 2020.

Shaukat, A.; Anwar, H.; Mahmood, A.; Hussain, G.; Rasul, A.; Umar, M. et al.; "Synthesis cum characterization of MgO and MnO nanoparticles and their assessment as antidiabetic and antioxidative agents in diabetic rat model". Phys. B (Amsterdam, Neth.), 602: 412570, 2021.

Ruan, S.; Guo, X.; Ren, Y.; Cao, G.; Xing, H.; Zhang, X.; "Nanomedicines based on trace elements for intervention of diabetes mellitus". Biomed. Pharmacother., 168: 115684, 2023.

Kumar, S.; Adjei, I.M.; Brown, S.B.; Liseth, O.; Sharma, B.; "Manganese dioxide nanoparticles protect cartilage from inflammation-induced oxidative stress". Biomaterials, 224: 119467, 2019.

Clemente, G.S.; Waarde, A. van; Antunes, I.F.; Dömling, A.; Elsinga, P.H.; "Arginase as a potential biomarker of disease progression: a molecular imaging perspective" Int. J. Mol. Sci., 21(15): 5291, 2020.

Slavu, L.M.; Rinaldi, R.; Di-Corato, R.D.; "Application in nanomedicine of manganese-Zinc ferrite nanoparticles" Appl. Sci., 11(23): 11183, 2021.

Dawadi, S.; Gupta, A.; Khatri, M.; Budhathoki, B.; Lamichhane, G.; Parajuli, N.; "Manganese dioxide nanoparticles: synthesis, application and challenges". Bull. Mater. Sci., 43: 1-10, 2020.

Chen, M.; Dong, C.; Shi, S.; "An Overview of Recent Advancements on Manganese-Based Nanostructures and Their Application for ROS-Mediated Tumor Therapy". ACS Materials Letters, 4(12): 2415–2433, 2022.

Abdelkawy, K.S.; Lack, K.; Elbarbry, F.; "Pharmacokinetics and Pharmacodynamics of Promising Arginase Inhibitors". Eur. J. Drug Metab. Pharmacokinet., 42(3): 355-370, 2017.

Haque, S.; Tripathy, S.; Patra, C.R.; "Manganese-based advanced nanoparticles for biomedical applications: Future opportunity and challenges". Nanoscale, 13(39): 16405–16426, 2021.

Zhang, J.; Yan, J.; Yang, Q.; Yan, Y.; Li, S.; Wang, L. et al.; "Arginine-modified dual emission photoluminescent nanocrystals for bioimaging at subcellular resolution". J. Biomater. Appl., 32(4): 533-542, 2017.

Xin, J.; Deng, C.; Aras, O.; Zhou, M.; Wu, C.; An, F.; "Chemodynamic nanomaterials for cancer theranostics". J. Nanobiotechnol., 19(1): 1–26, 2021.

Li, H.; Xia, P.; Pan, S.; Qi, Z.; Fu, C.; Yu, Z. et al.; "The advances of ceria nanoparticles for biomedical applications in orthopaedics". Int. J. Nanomed., 15: 7199–7214, 2020.

Haque, S.; Tripathy, S.; Patra, C.R.; "Manganese-based advanced nanoparticles for biomedical applications: Future opportunity and challenges". Nanoscale, 13(39): 16405-16426 , 2021.

Smirnovienė, J.; Baranauskienė, L.; Zubrienė, A.; Matulis, D.; "A standard operating procedure for an enzymatic activity inhibition assay". Eur. Biophys. J., 50(3–4): 345-352, 2021.

Kałas, W.; "Should Nano-Particles be Weighed or Counted? Technical Considerations to In Vitro Testing Originated from Corpuscular Nature of Nano-Particles". Arch. Immunol. Ther. Exp., 69(1): 23, 2021.

Chenthamara, D.; Subramaniam, S.; Ramakrishnan, S.G.; Krishnaswamy, S.; Essa, M.M.; Lin, F.-H. et al.; "Therapeutic efficacy of nanoparticles and routes of administration". Biomater. Res., 23(1): 20, 2019.

Legat, J.; Matczuk, M.; Scaletti, F.; Messori, L.; Timerbaev, A.; Jarosz, M.; "Erratum to: CE Separation and ICP-MS Detection of Gold Nanoparticles and Their Protein Conjugates". Chromatographia, 80(11): 1695-1700, 2017.

Zhang, L.; Li, L.; "Colorimetric thrombin assay using aptamer functionalized gold nanoparticles acting as a peroxidase mimetic". Microchim. Acta, 183(1): 485-490, 2016.

Murthy, S.; Effiong, P.; Fei, C.C.; "Metal oxide nanoparticles in biomedical applications". Met. oxide powder technol., 2020: 233-251, 2020.

Jayaselvan, L.; Rajan, S.T.; Sambandam, C.G.; "Structural and phase analysis of pure and metal ion doped Mn2O3 nanoparticles prepared by microwave assisted sol-gel method". Rasayan J. Chem., 13(4): 2223-2229, 2020.

Rasheed, R.T.; Al-Algawi, S.D.; Kareem, H.H.; Mansoor, H.S.; "Preparation and Characterization of Hematite Iron Oxide (α-Fe2O3) by Sol-Gel Method". Chem. Sci. J., 9(197): 2, 2018.

Post, J.E.; McKeown, D.A.; Heaney, P.J.; "Raman spectroscopy study of manganese oxides: Layer structures". Am. Mineral., 106(3): 351-366, 2021.

Lakshmi, R.V; Bera, P.; Hiremath, M.; Dubey, V.; Kundu, A.K.; Barshilia, H.C.; "Structural, magnetic, and dielectric properties of solution combustion synthesized LaFeO3, LaFe0.9 Mn0.1O3, and LaMnO3 perovskites". Phys. Chem. Chem. Phys., 24(9): 5462-5478, 2022.

Sahib, R.S.; Naser, J.A.; "Preparation, Characterization and Surface Area Properties of Manganese Oxide Nanoparticles". Ann. R.S.C.B., 25(5): 2962-2969, 2021.

Talebi, R.; "New method for preparation Mn2O3–TiO2 nanocomposites and study of their photocatalytic properties". J. Mater. Sci.: Mater. Electron., 28(11): 8316-8321, 2017.

Mortier, J.; Prévost, J.R.C.; Sydow, D.; Teuchert S.; Omieczynski C.; Bermudez M.; et al.; "Arginase Structure and Inhibition: Catalytic Site Plasticity Reveals New Modulation Possibilities". Sci. Rep., 7(1): 13616, 2017.

Pant, K.; Bilwes, A.M.; Adak, S.; Stuehr, D.J.; Crane, B.R.; "Structure of a nitric oxide synthase heme protein from Bacillus subtilis". Biochemistry, 41(37): 11071-11079, 2002.

Kim, J.; Kim, H.Y.; Song, S.Y.; Go, S.; Sohn, H.S.; Baik, S. et al.; "Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis treatment". ACS Nano., 13(3): 3206-3217, 2019.

Roth, J.; Ponzoni, S.; Aschner, M.; "Manganese homeostasis and transport". Met. Ion life Sci., 12: 169–201, 2013.

Downloads

Published

2024-03-15

Issue

Section

Articles

How to Cite

(1)
Synthesis of Mn2O3 Nanoparticles and Determination of Its Inhibition Effect On Sera of Iraqi Patients With Diabetes Mellitus Type-2 and Diabetes Nephropathy. ANJS 2024, 27 (1), 14-22. https://doi.org/10.22401/7gfa1v29.